Ionis appoints Onaiza Cadoret-Manier as chief corporate development and commercial officer
- Thursday, January 9, 2020, 7:15
- PR Newswire
- Add a comment
CARLSBAD, Calif., Jan. 9, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, today announced the appointment of Onaiza Cadoret-Manier as chief corporate development and commercial officer reporting to Brett P. Monia, Ph.D., chief…
About the Author
admin has written 21793 stories on this site.